Found: 4
Select item for more details and to access through your institution.
Combining Conventional Therapies with Intratumoral Injection of Autologous Dendritic Cells and Activated T Cells to Treat Patients with Advanced Cancers.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1174, p. 41, doi. 10.1111/j.1749-6632.2009.04934.x
- By:
- Publication type:
- Article
Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 1, p. 53, doi. 10.1007/s00262-003-0419-2
- By:
- Publication type:
- Article
Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell--Activated T Cell Based Immunotherapy and Intensity--Modulated Radiotherapy.
- Published in:
- Cancers, 2011, v. 3, n. 2, p. 2223, doi. 10.3390/cancers3022223
- By:
- Publication type:
- Article
Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines bydirect recognition and antibody directed cellular cytotoxicity.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2010, v. 29, p. 134, doi. 10.1186/1756-9966-29-134
- By:
- Publication type:
- Article